Search

Search Constraints

You searched for: Author/Creator Chung, Hyun Cheol

Search Results

1. 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study. (4th December 2020)

2. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Issue 10 (October 2020)

3. Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. Issue 1 (4th February 2019)

4. Changing treatment patterns in elderly patients with resectable colon cancer. Issue 3 (21st December 2012)

6. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer. Issue 1 (21st October 2019)

7. Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17–25]. (September 2018)

8. CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (12th November 2021)

9. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy. Issue 1 (January 2016)